The global stem cell drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor expected to drive the market growth is the rising burden of chronic diseases along with the increasing investment in the R&D for stem cell researches. Furthermore, increasing demand for stem cell-based therapies has accelerated the need for innovation and development of the product are some factors that propel the growth of the stem cells drug market during the forecast period. According to the World Health Organization (WHO), there is a 57% increment in chronic disease in 2020. This, in turn, is driving the demand for stem cell drugs.
(Get 15% Discount on Buying this Report)
A full report of Global Stem Cell Drug Market is available at: https://orionmarketreports.com/stem-cell-drug-market/96319/
Some major players in the market include Takeda Pharmaceutical Co., Ltd., Juno Therapeutics, Inc. (Bristol-Myers Squibb Co.), and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2020, Baylx Inc. announced that the company received approval from the United States Food and Drug Administration (USFDA) for the investigational new drug (IND) umbilical cord mesenchymal stem cells product. Additionally, in May 2020, Celavie Biosciences, LLC announced that the company is developing regenerative stem cell therapies for treating central nervous system disorders and Parkinson’s disease. The company also released successful results for their clinical trial of OK99 stem cells for Parkinson’s disease.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Product
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Takeda Pharmaceutical Co., Ltd., Juno Therapeutics, Inc. (Bristol-Myers Squibb Co.), and Novartis International AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Stem Cell Drug Market Report by Segment
By Product
- Cord Blood-Derived
- Adipose-Derived
- Bon Marrow-Derived
- Others
By Application
- Acute Graft-versus-Host Disease
- Crohn’s Disease
- Amyotrophic Lateral Sclerosis
- Osteoarthritis
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
